HRP20030959A2 - - Google Patents
Info
- Publication number
- HRP20030959A2 HRP20030959A2 HR20030959A HRP20030959A HRP20030959A2 HR P20030959 A2 HRP20030959 A2 HR P20030959A2 HR 20030959 A HR20030959 A HR 20030959A HR P20030959 A HRP20030959 A HR P20030959A HR P20030959 A2 HRP20030959 A2 HR P20030959A2
- Authority
- HR
- Croatia
- Prior art keywords
- disorders
- azulenes
- neurotransmitters
- dibenzo
- aza
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HR20030959A HRP20030959A2 (ru) | 2003-11-21 | 2003-11-21 | |
| JP2006540631A JP2007512308A (ja) | 2003-11-21 | 2004-11-19 | 中枢神経系の疾患及び障害の治療及び予防用医薬製剤を製造するための３−アザ−１−オキサ−ジベンゾ［ｅ，ｈ］アズレン類の使用 |
| ES04798733T ES2289573T3 (es) | 2003-11-21 | 2004-11-19 | Uso de 3-aza-1-oxa-dibenzo(e,h)azulenos para la fabricacion de formulaciones farmaceuticas para el tratamiento y la prevencion de enfermedades y trastornos del sistema nervioso central. |
| PCT/HR2004/000054 WO2005049036A1 (en) | 2003-11-21 | 2004-11-19 | USE OF 3-AZA-1-OXA-DIBENZO [e,h] AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEAS AND DISORDERS |
| CNA2004800394544A CN1901918A (zh) | 2003-11-21 | 2004-11-19 | 3－氮杂－1－氧杂－二苯并[e,h]薁用于制备治疗和预防中枢神经系统疾病和障碍的药物制剂的用途 |
| EP04798733A EP1684766B1 (en) | 2003-11-21 | 2004-11-19 | USE OF 3-AZA-1-OXA-DIBENZO i e,h /i AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEAS AND DISORDERS |
| US10/595,938 US20070111990A1 (en) | 2003-11-21 | 2004-11-19 | 3-Aza-1-oxa-dibenzo[e,h]azulenes for the treatment of central nervous system diseases and disorders |
| DE602004007289T DE602004007289T2 (de) | 2003-11-21 | 2004-11-19 | Verwendung von 3-aza-1-oxadibenzo(e,h)azulenen zur Herstellung von pharmazeutischen Formulierungen für die Behandlung und Prävention von Erkrankungen und Störungen des zentralen Nervensystems |
| CA002546591A CA2546591A1 (en) | 2003-11-21 | 2004-11-19 | Use of 3-aza-1-oxa-dibenzo [e,h] azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| AT04798733T ATE365556T1 (de) | 2003-11-21 | 2004-11-19 | Verwendung von 3-aza-aoxa-dibenzo(e,h)azulenen zur herstellung von pharmazeutischen formulierung für die behandlung und prävention von erkrankungen und störungen des zentralen nervensystems |
| HK07101111A HK1098670A1 (en) | 2003-11-21 | 2007-01-31 | Use of 3-aza-1-oxa-dibenzo Äe,hÜ azulenes for the manufacture of pharmaceutical formulations for thetreatment and prevention of central nervous syste m disease and disorders |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HR20030959A HRP20030959A2 (ru) | 2003-11-21 | 2003-11-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20030959A2 true HRP20030959A2 (ru) | 2005-10-31 |
Family
ID=34611163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20030959A HRP20030959A2 (ru) | 2003-11-21 | 2003-11-21 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20070111990A1 (ru) |
| EP (1) | EP1684766B1 (ru) |
| JP (1) | JP2007512308A (ru) |
| CN (1) | CN1901918A (ru) |
| AT (1) | ATE365556T1 (ru) |
| CA (1) | CA2546591A1 (ru) |
| DE (1) | DE602004007289T2 (ru) |
| ES (1) | ES2289573T3 (ru) |
| HK (1) | HK1098670A1 (ru) |
| HR (1) | HRP20030959A2 (ru) |
| WO (1) | WO2005049036A1 (ru) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3711489A (en) * | 1971-03-31 | 1973-01-16 | Pfizer | Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles |
| NL7605526A (nl) * | 1976-05-24 | 1977-11-28 | Akzo Nv | Nieuwe tetracyclische derivaten. |
| US4198421A (en) * | 1978-11-30 | 1980-04-15 | E. I. Du Pont De Nemours And Company | Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles |
| FR2504140A1 (fr) * | 1981-04-16 | 1982-10-22 | Centre Nat Rech Scient | Nouveaux derives tetracycliques de la dibenzazepine, leur procede de preparation et les compositions pharmaceutiques en renfermant |
| US4666716A (en) * | 1984-09-04 | 1987-05-19 | Richardson-Vicks Inc. | Antidiarrheal compositions and use thereof |
| ES2130135T3 (es) * | 1990-01-11 | 1999-07-01 | Upjohn Co | Nuevos compuestos heterociclicos de 6,7,8,9-tetrahidro-3h-benz(e)indol con actividad terapeutica sobre el sistema nervioso central. |
| UA52778C2 (ru) * | 1997-10-10 | 2003-01-15 | Янссен Фармацевтика Н.В. | Галогенозамещенные тетрациклические производные тетрагидрофурана, способ их получения и композиции на их основе |
| US6015557A (en) * | 1999-02-24 | 2000-01-18 | Tobinick; Edward L. | Tumor necrosis factor antagonists for the treatment of neurological disorders |
| HRP20020304B1 (en) * | 2002-04-10 | 2008-04-30 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof |
-
2003
- 2003-11-21 HR HR20030959A patent/HRP20030959A2/xx not_active Application Discontinuation
-
2004
- 2004-11-19 EP EP04798733A patent/EP1684766B1/en active Active
- 2004-11-19 WO PCT/HR2004/000054 patent/WO2005049036A1/en active IP Right Grant
- 2004-11-19 DE DE602004007289T patent/DE602004007289T2/de active Active
- 2004-11-19 ES ES04798733T patent/ES2289573T3/es active Active
- 2004-11-19 JP JP2006540631A patent/JP2007512308A/ja active Pending
- 2004-11-19 CA CA002546591A patent/CA2546591A1/en not_active Abandoned
- 2004-11-19 AT AT04798733T patent/ATE365556T1/de not_active IP Right Cessation
- 2004-11-19 US US10/595,938 patent/US20070111990A1/en not_active Abandoned
- 2004-11-19 CN CNA2004800394544A patent/CN1901918A/zh active Pending
-
2007
- 2007-01-31 HK HK07101111A patent/HK1098670A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1901918A (zh) | 2007-01-24 |
| JP2007512308A (ja) | 2007-05-17 |
| US20070111990A1 (en) | 2007-05-17 |
| EP1684766A1 (en) | 2006-08-02 |
| CA2546591A1 (en) | 2005-06-02 |
| DE602004007289D1 (de) | 2007-08-09 |
| HK1098670A1 (en) | 2007-07-27 |
| ATE365556T1 (de) | 2007-07-15 |
| WO2005049036A1 (en) | 2005-06-02 |
| EP1684766B1 (en) | 2007-06-27 |
| DE602004007289T2 (de) | 2008-03-06 |
| ES2289573T3 (es) | 2008-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200407305A (en) | Novel compounds | |
| TW200510301A (en) | Novel compounds | |
| TW200510303A (en) | Novel compounds | |
| TW200531689A (en) | Therapeutic agents | |
| HK1096673A1 (en) | Compositions useful as inhibitors of protein kinases | |
| TW200630096A (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
| TW200635903A (en) | Therapeutic agents | |
| DE60229530D1 (de) | Substituierte piperazine als modulatoren des melanocortinrezeptors | |
| MX2007012374A (es) | Metodos y composiciones para el tratamiento de condiciones relacionadas con cns. | |
| MXPA05013366A (es) | Derivados de benzazepina utiles para el tratamiento de enfermedades asociadas con el receptor 5ht2c. | |
| UA87856C2 (ru) | Алкильные производные как модуляторы метаботропных рецепторов глутамата | |
| SE0202241D0 (sv) | Novel Compounds | |
| TW200633986A (en) | Therapeutic agents | |
| TW200504034A (en) | Therapeutic agents | |
| MX2007006754A (es) | Derivados de indenilo y uso de los mismos para el tratamiento de trastornos neurologicos. | |
| TW200734324A (en) | Therapeutic agents | |
| HRP20030885A2 (en) | USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS | |
| JO2724B1 (en) | 3-Alternative-5 -6-Amino Alkyl Indole-2-Carboxyl Acid Amide and Related Isotopes as Casein Kinase Inhibitors | |
| HRP20030956A2 (en) | USE OF 1,2-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANU | |
| HRP20030959A2 (ru) | ||
| HRP20030957A2 (en) | USE OF 1-THIA-3-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS | |
| HK1098668A1 (en) | Use of 1,3-diaza-dibenzo Äe.hÜ azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders | |
| HRP20030955A2 (en) | USE OF 1-OXADIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS | |
| IL179030A0 (en) | Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders | |
| UA84701C2 (ru) | Замещенные индолы, способ их получения, их использования |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20071018 Year of fee payment: 5 |
|
| PNAN | Change of the applicant name, address/residence |
Owner name: GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O., |
|
| ODBI | Application refused |